Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT

Completed · Phase 2 · Has a placebo group

Conditions studied: Peanut Allergy

In brief

This is a multi-center, randomized, double-blind placebo controlled study of efficacy and safety of characterized peanut oral immunotherapy in peanut allergic individuals.

Key facts

Study ID

NCT01987817

Run by

Aimmune Therapeutics, Inc.

People needed

56

Starts

2014-02-06

Expected to finish

2015-01-07

Last updated by the study team

2021-11-30

Who can join

Age: 4 and older, up to 26. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arkansas Children's Hospital — Little Rock, Arkansas, United States
• UC San Diego — San Diego, California, United States
• Boston Children's Hospital — Boston, Massachusetts, United States
• Mount Sinai Medical Center — New York, New York, United States
• University of North Carolina — Chapel Hill, North Carolina, United States
• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
• The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
• Children's Medical Center Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.